Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 22.0 Contact Hours.
This activity is supported by an educational grants from AbbVie, AstraZeneca, BeyondSpring Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Celgene Corporation, Genentech, Lilly, Merck Sharp & Dohme Corp, Novartis Pharmaceuticals Corporation, and Takeda Oncology.
For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
18th Annual International Lung Cancer Congress®- Call for Poster Abstracts!
The 18th Annual International Lung Cancer Congress®- Program Chairs invite you to submit your abstracts for the 18th Annual International Lung Cancer Congress®- to be held July 27th-29th 2017 at the Hyatt Regency Huntington Beach in Huntington Beach, CA.
The abstract portal is now closed.
All poster abstracts must be submitted electronically through the congress' online abstract submission system.
Your abstract should be a short description of your work focused on lung cancers, containing all the elements necessary to define your goals and results to the reader. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. The formal poster session is not designated for credit.
Share your research or best practices with your peers. Categories of submission include:
Note: Trial in progress and encore abstracts are accepted.
The Program chairs will evaluate the scientific quality of the submitted abstracts on the basis of the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed.
Notification of acceptance, or regret, will be delivered via e-mail to the presenter(s) of each poster abstract, by mid - June. Please note that an author is required to be present during the poster session.
If accepted for presentation, abstracts and posters will be available for viewing online on the 2017 congress website during and after the conference. The posters will be displayed for the length of the conference. The presentation at the congress should reflect the submitted abstract title, authorship, and content of the presentation at the congress must match the submitted abstract.
All presenters must register to attend the 18th Annual International Lung Cancer Congress®.
Please click here to register.
Components of the Abstract Body-Limit: 2500 Characters (1 table allowed)
Please submit any questions pertaining to abstract submissions to firstname.lastname@example.org using the subject line "International Lung Cancer Congress® Abstract QUESTION."
Author Consent and Waiver of Claims
Note: The hotel is expected to sell out and likely to do so before the discounted cut-off date of June 26th 2017. Reservations may be made online here.
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Apr 28, 2018
April 28, 2018
New York, NY